Literature DB >> 30413382

Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer.

Anna Fagotti1, Giovanni Scambia2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30413382     DOI： 10.1016/S1470-2045(18)30625-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network.

Authors:  Hélène Bonsang-Kitzis; Nabilah Panchbhaya; Anne-Sophie Bats; Eric Pujade-Lauraine; Patricia Pautier; Charlotte Ngô; Marie-Aude Le Frère-Belda; Elsa Kalbacher; Anne Floquet; Dominique Berton-Rigaud; Claudia Lefeuvre-Plesse; Michel Fabbro; Isabelle Ray-Coquard; Fabrice Lécuru
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

2.  Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.

Authors:  Sarah L Coleridge; Andrew Bryant; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-02-05

3.  Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.

Authors:  Sarah L Coleridge; Andrew Bryant; Thomas J Lyons; Richard J Goodall; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2019-10-31

4.  Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer.

Authors:  Nicholas Cardillo; Eric J Devor; Silvana Pedra Nobre; Andreea Newtson; Kimberly Leslie; David P Bender; Brian J Smith; Michael J Goodheart; Jesus Gonzalez-Bosquet
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

5.  Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.

Authors:  Sarah L Coleridge; Andrew Bryant; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.